Cargando…
Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
The metastasis of breast cancer is one of the main factors resulting in the high fatality of patients. Although many antagonists have been developed to inhibit the metastasis of breast cancer, their practical application has been limited because of the poor solubility of many chemotherapeutic drugs...
Autores principales: | Liu, Changliang, Duan, Hongyang, Zhao, Zijian, Li, Wenzhe, Ma, Lilusi, Fang, Xiaocui, Wang, Chen, Yang, Yanlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091381/ https://www.ncbi.nlm.nih.gov/pubmed/35558209 http://dx.doi.org/10.1039/c8ra08526a |
Ejemplares similares
-
Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
por: Liu, Changliang, et al.
Publicado: (2019) -
Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
por: Liu, Changliang, et al.
Publicado: (2018) -
Modulation of β-amyloid aggregation by graphene quantum dots
por: Liu, Changliang, et al.
Publicado: (2019) -
Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
por: Fang, Xiaocui, et al.
Publicado: (2017) -
Acetylation of PAMAM dendrimers for cellular delivery of siRNA
por: Waite, Carolyn L, et al.
Publicado: (2009)